The FDA approved Edarbi (azilsartan medoxomil), a new angiotensin receptor blocker, for the treatment of hypertension in adults.
Alexander White, PharmD Candidate
Advertisement
Articles by Alexander White, PharmD Candidate
Advertisement
Latest Updated Articles
- Takeda Pharmaceuticals America, Inc's Edarbi
Published: May 16th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Incidence of VAIs in Patients With Chronic Kidney Disease on Dialysis Relatively Low
4
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
5
